STRS Ohio’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-173,200
Closed -$545K 2377
2020
Q3
$545K Hold
173,200
﹤0.01% 1282
2020
Q2
$504K Buy
173,200
+14,300
+9% +$45.2K ﹤0.01% 1301
2020
Q1
$448K Sell
158,900
-40,200
-20% -$130K ﹤0.01% 1217
2019
Q4
$646K Sell
199,100
-63,900
-24% -$186K ﹤0.01% 1259
2019
Q3
$568K Buy
263,000
+63,100
+32% +$169K ﹤0.01% 1178
2019
Q2
$627K Buy
199,900
+6,600
+3% +$21.4K ﹤0.01% 1125
2019
Q1
$719K Sell
193,300
-17,700
-8% -$59.8K ﹤0.01% 995
2018
Q4
$611K Sell
211,000
-67,900
-24% -$187K ﹤0.01% 1057
2018
Q3
$733K Sell
278,900
-29,200
-9% -$71.7K ﹤0.01% 1107
2018
Q2
$720K Buy
308,100
+61,100
+25% +$171K ﹤0.01% 1159
2018
Q1
$726K Hold
247,000
﹤0.01% 1089
2017
Q4
$676K Buy
247,000
+26,000
+12% +$79.9K ﹤0.01% 1163
2017
Q3
$749K Sell
221,000
-51,900
-19% -$144K ﹤0.01% 1088
2017
Q2
$674K Sell
272,900
-39,300
-13% -$90.4K ﹤0.01% 1151
2017
Q1
$708K Sell
312,200
-23,600
-7% -$52.2K ﹤0.01% 1083
2016
Q4
$711K Buy
335,800
+116,800
+53% +$326K ﹤0.01% 1102
2016
Q3
$733K Sell
219,000
-15,400
-7% -$48.9K ﹤0.01% 1001
2016
Q2
$736K Buy
234,400
+14,200
+6% +$47.4K ﹤0.01% 986
2016
Q1
$733K Buy
220,200
+61,500
+39% +$192K ﹤0.01% 973
2015
Q4
$561K Hold
158,700
﹤0.01% 1236
2015
Q3
$798K Buy
158,700
+11,700
+8% +$67K ﹤0.01% 954
2015
Q2
$945K Buy
147,000
+6,300
+4% +$42.2K ﹤0.01% 895
2015
Q1
$989K Buy
140,700
+6,300
+5% +$45.6K ﹤0.01% 801
2014
Q4
$1.04M Buy
134,400
+5,000
+4% +$39.6K ﹤0.01% 782
2014
Q3
$967K Buy
129,400
+13,200
+11% +$123K ﹤0.01% 775
2014
Q2
$1.13M Sell
116,200
-14,700
-11% -$131K 0.01% 720
2014
Q1
$1.09M Buy
130,900
+1,300
+1% +$11.1K ﹤0.01% 696
2013
Q4
$1.09M Sell
129,600
-22,500
-15% -$190K ﹤0.01% 698
2013
Q3
$1.21M Buy
152,100
+3,100
+2% +$24.9K 0.01% 719
2013
Q2
$1.15M Buy
+149,000
New +$1.16M ﹤0.01% 756

Other funds holding PDLI